Biohit Oyj

Regulatory Filings • Mar 26, 2021

Biohit’s CEO is on sick leave

Biohit’s CEO is on sick leave

Biohit Oyj  Stock Exchange Release

26 March 2021 at 09:00 am local time (EET)

Biohit Oyj´s CEO Semi Korpela is on sick leave effective as of 22nd of March
2021. During sick leave, the duties of the CEO are performed by the Chairman of
the Board Osmo Suovaniemi.

Helsinki, 26 March 2021

Biohit Oyj
Board of Directors

Additional information:

Osmo Suovaniemi, Chairman of the Board of Directors

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit Oyj in brief

Biohit is a globally operating Finnish biotechnology company. Biohit mission is
“Innovating for Health” – we produce innovative products and services to promote
research and early diagnosis. Biohit is headquartered in Helsinki. Finland. and
has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on
Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com